Article
The PTPN22 1858T gene variant in type 1 diabetes is associated with reduced residual beta-cell function and worse metabolic control.
Diabetes care - 1 Jun 2008
Petrone Antonio, Spoletini Marialuisa, Zampetti Simona, Capizzi Marco, Zavarella Sara, Osborn John, Pozzilli Paolo, Buzzetti Raffaella
Abstract excerpt
OBJECTIVE: Evidence has been reported for a new susceptible locus for type 1 diabetes, the protein tyrosine phosphatase nonreceptor type 2 (PTPN22), which encodes a lymphoid-specific phosphatase. The aim of the study was to evaluate the influence of the C1858T variant of the PTPN22 gene on beta-cell function as measured by C-peptide levels from time of disease diagnosis through 12 months follow-up in a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
